Starbucks Corp
SBUX
$0.00
+0.94%
Starbucks Corp is a global leader in the restaurant industry, operating as the world's largest and most recognized coffee brand. It is defined by its massive footprint of nearly 41,000 company-operated and licensed cafes worldwide and its core advantage in offering highly customizable beverages.…
SBUX
Starbucks Corp
$0.00
Related headlines
Investment Opinion: Should I buy SBUX Today?
Based on a synthesis of the data, the objective assessment is a Hold. The stock is not a clear buy due to its elevated valuation (P/E of 52.58) amidst deteriorating fundamentals, particularly profitability and balance sheet health. However, it is not a clear sell either, given its strong brand, global footprint, and robust free cash flow which could fund a recovery. Investors should await clearer signs of successful margin restoration and debt management before establishing new positions.
Sign up to view all
SBUX 12-Month Price Forecast
The investment thesis hinges entirely on a successful operational turnaround. The current high valuation leaves little room for error, creating a balanced risk/reward profile skewed slightly negative in the near term.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Starbucks Corp's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
12 analysts
Implied Upside
—
vs. current price
Analyst Count
12
covering this stock
Price Range
$0 - $0
Analyst target range
Data not available for a specific consensus target price or ratings distribution. The provided analyst data includes forward estimates for EPS and revenue, but lacks a summarized target. Recent institutional rating actions show a mix of 'Hold', 'Neutral', 'Overweight', and 'Buy' stances, with RBC Capital downgrading the stock from 'Outperform' to 'Sector Perform' in mid-March 2026.
Bulls vs Bears: SBUX Investment Factors
Starbucks presents a classic turnaround story with significant tension. Its powerful brand and cash generation are offset by severe margin compression and a strained balance sheet. The stock's recent decline reflects investor skepticism about the cost and timeline of its recovery.
Bullish
- Strong Free Cash Flow: TTM FCF of $2.34B provides financial flexibility for turnaround.
- Dominant Global Brand: World's largest coffee brand with ~41,000 stores offers scale advantage.
- Revenue Growth Persists: Latest quarterly revenue grew 5.43% YoY despite challenges.
- Attractive Forward P/E: Forward P/E of 30.38 is lower than trailing, implying earnings recovery.
Bearish
- Severe Profitability Erosion: Net margin collapsed to 2.96% from 8.31% YoY.
- Weak Financial Health: Negative equity (Debt/Equity -3.29) and low current ratio (0.72).
- High Valuation Multiples: Trailing P/E of 52.58 is high given declining profitability.
- Recent Negative Momentum: Stock down 8.60% in one month, underperforming S&P 500.
SBUX Technical Analysis
Overall Assessment: The stock has shown significant volatility over the last six months, with a notable decline from a peak above $101 in March 2026 to a current price of $89.59. The 6-month price change is positive at 3.31%, but this masks a sharp recent pullback of 8.60% over the past month, indicating a shift in momentum.
Short-term Performance: Over the last three months, the stock has gained 6.39%, significantly outperforming the S&P 500, which fell 4.63% in the same period. However, the one-month performance is negative at -8.60%, underperforming the market's -5.25% decline, suggesting recent weakness.
Current Position: The current price of $89.59 sits roughly 14.5% below its 52-week high of $104.82 and about 18.6% above its 52-week low of $75.5. This places it in the lower-middle portion of its yearly range, following a retreat from recent highs.
Beta
0.93
0.93x market volatility
Max Drawdown
-32.3%
Largest decline past year
52-Week Range
$76-$105
Price range past year
Annual Return
-7.9%
Cumulative gain past year
| Period | SBUX Return | S&P 500 |
|---|---|---|
| 1m | -6.5% | -3.7% |
| 3m | +7.4% | -4.1% |
| 6m | +4.6% | -2.1% |
| 1y | -7.9% | +16.1% |
| ytd | +7.7% | -3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SBUX Fundamental Analysis
Revenue & Profitability: The most recent quarterly revenue (Q1 2026) was $9.91 billion, representing a year-over-year growth of 5.43%. However, profitability has been pressured, with the net margin for that quarter at 2.96%, a significant decline from the 8.31% net margin in the year-ago quarter (Q1 2025).
Financial Health: The company's financial health shows strain, with a debt-to-equity ratio of -3.29, indicating negative shareholder equity. The current ratio is 0.72, suggesting potential liquidity constraints. Positively, trailing twelve-month free cash flow is a robust $2.34 billion.
Operational Efficiency: Operational metrics are mixed. Return on Assets (ROA) is a modest 6.87%, but Return on Equity (ROE) is deeply negative at -22.93%, primarily due to the negative equity base. The quarterly gross margin of 15.63% in Q1 2026 is notably lower than the 24.49% from Q1 2025, indicating margin compression.
Quarterly Revenue
$9.9B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.15%
Latest Quarter
Free Cash Flow
$2.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SBUX Overvalued?
Valuation Level: Given the company's positive net income ($293 million in the latest quarter), the primary valuation metric is the P/E ratio. The trailing P/E is elevated at 52.58, while the forward P/E is 30.38, reflecting high expectations for future earnings growth to justify the current price.
Peer Comparison: Data not available for a direct industry average comparison. However, the Price-to-Sales (P/S) ratio of 2.63 and EV-to-Sales of 3.29 provide alternative valuation perspectives. The high P/E ratios suggest the market is pricing in a successful turnaround from current profitability challenges.
PE
52.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~184x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
22.5x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is execution risk within the company's turnaround plan. Profitability has sharply declined, with gross margin falling from 24.49% to 15.63% year-over-year in the latest quarter, indicating significant cost pressures or pricing challenges. This raises questions about the sustainability of its 15-year dividend growth streak, given the high payout ratio.
Financial health is a major concern. The company has negative shareholder equity (Debt/Equity of -3.29) and a current ratio of 0.72, suggesting potential liquidity constraints if operating conditions worsen. Furthermore, the stock is highly sensitive to consumer discretionary spending, and a weakening economic environment could further pressure sales growth and margins.
Competitive and operational risks are also present. The news highlights investor concern over the high costs of the turnaround. Additionally, competitive threats are evolving, as seen with Luckin's stakeholder acquiring Blue Bottle Coffee, signaling intensified competition in the premium coffee segment globally.
FAQ
The key risks are operational and financial. Operationally, the company must reverse severe gross margin compression (down nearly 900 bps YoY). Financially, the balance sheet is weak with negative equity (Debt/Equity -3.29) and a low current ratio of 0.72. There is also dividend sustainability risk due to a high payout ratio, and competitive risks from players like Luckin and Dutch Bros.
The 12-month outlook is highly uncertain, centered on the success of its turnaround. The base case (50% probability) sees the stock trading between $85 and $100, as it grapples with recovery. A successful bull case (25%) could see it retest its 52-week high of $104.82 and beyond. A failed turnaround bear case (25%) could see it fall towards its 52-week low of $75.5.
Based on current fundamentals, SBUX appears overvalued. The trailing P/E of 52.58 is extremely high for a company experiencing margin collapse and negative shareholder equity. The forward P/E of 30.38 suggests the market expects significant earnings growth, making the stock fairly valued only if those optimistic forecasts are met. The current price reflects hope, not current performance.
Currently, SBUX is not a compelling buy for most investors. While the brand is strong, the stock's high trailing P/E of 52.58 is difficult to justify given the sharp decline in net margin to 2.96%. The investment case requires a belief in a successful and timely turnaround, which carries significant execution risk. A more prudent approach would be to monitor progress on margin recovery.
SBUX is unsuitable for short-term investment due to its high volatility and lack of near-term catalysts. It is a speculative long-term investment for investors who believe deeply in management's ability to execute a multi-year turnaround. The long-term thesis depends on restoring profitability, managing debt, and reigniting growth, which will take several quarters, if not years, to materialize.